"Fundación Zambrano es una clínica de referencia en oftalmología de alta complejidad que trabaja para asegurar la salud visual de la comunidad a través de la atención médica de excelencia, la capacitación profesional, la investigación y la acción social."

During the past decade, Fundacion Zambrano conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Zambrano" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Zambrano" are "Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Fundacion Zambrano" in a lesser frequency.

Most popular intervention types in "Fundacion Zambrano" are "Drug" (7 trials), "Procedure" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Lampalizumab" (1 trials) and "Sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Zambrano" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion Zambrano". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fundacion Zambrano, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Zambrano, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".